Rankings
▼
Calendar
DNLI Q4 2017 Earnings — Denali Therapeutics Inc. Revenue & Financial Results | Market Cap Arena
DNLI
Denali Therapeutics Inc.
$3B
Q4 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$24M
Net Income
-$23M
EPS (Diluted)
$-0.74
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$18M
Free Cash Flow
-$19M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$487M
Total Liabilities
$21M
Stockholders' Equity
$466M
Cash & Equivalents
$218M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$24M
-$20M
-18.5%
Net Income
-$23M
-$19M
-18.3%
← FY 2017
All Quarters
Q1 2018 →